Strides’ New CEO Is Former Cipla COO

Strides Names R Ananthanarayanan To Replace Arun Kumar As CEO

Arun Kumar is stepping down as chief executive of Strides Pharma to focus on overall corporate strategy and the company’s return to injectables. He will be replaced by former Cipla chief operating officer R Ananthanarayanan.

Cipla COO Dr R Ananthanarayanan
New Strides CEO R Ananthanarayanan Recently Stepped Down As Cipla COO

More from Leadership

More from Generics Bulletin